Menu

Namaste Miniatures

Smaller Horses Too Cute To Ignore

Jacob Gottlieb; Founder of Visium Plots a Comeback in Hedge Fund Investment

Like a phoenix, Jacob Gottlieb wants to rise again. After closing his hedge fund in 2016, Gottlieb is considering on raising money to start another hedge fund. Jacob Gottlieb liquidated his Visium Asset Management LP after his staffers were accused of insider trading. However, Gottlieb was never accused of wrongdoing.

In an interview where he highlighted his plans for a comeback, Mr. Gottlieb said that he loves investing and that is what he has been doing since he was a teenager. He went on to say that that is what he wants to do for the rest of his life.

As a testimony to his determination to investments, the 46 year old has opened a family office by the name Altium Capital which he uses mostly for managing his personal wealth. At Altium, Mr Jacob Gottlieb works with other six employees, whereby his brother, Mark Gottlieb serves as the Chief Operating Officer. Like Visium, Altium Capital focuses its investments mainly in healthcare, as well as stock trading in the same.

At the time when Visium Asset Management was winding up, Mr. Gottlieb had promised that he had not the luxury to relax for long. True to his word, it seems like Mr. Gottlieb is making a comeback with a thud. Being a medical doctor, it seems his main area of focus is healthcare-centered hedge fund. While giving his opinion on why he wants to focus on healthcare, he pointed out that most firms have gone public thus their potential for value creation and destruction is huge.

Mr. Jacob Gottlieb had founded Visium in 2005 and at the peak of its growth; the company was managing a fund worth $8 billion. According to Wall Street Journal, Visium’s healthcare flagship fund, Visium Balanced Fund had an annualized return of 14.3% from 2001 to 2015. Of this, four years (2001-2005), Mr. Gottlieb managed the strategy in different accounts. However, in 2016, the fund lost 9.3% when senior employees of the company were charged of insider trading and mismarking securities.